Tonix Pharmaceuticals (TNXP) announced the publication of a paper entitled, “Recombinant Chimeric Horsepox Virus, TNX-801, is Attenuated Relative to Vaccinia Virus Strains in Both In Vitro and In Vivo ...
How it works: experts take the patient's T-cells and reprogram them in the lab so that they can recognize structures on cancer cells with the help of a receptor called chimeric antigen receptor (CAR).
The field of engineered cell therapies is rapidly advancing, offering promising new treatments for autoimmune conditions and cancer. Recent applications, particularly the use of chimeric antigen ...